|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ù������ |
|
ϵͳ�Ժ���Ǵ� |
| ��������������� | |
|
������� |
|
�������� |
|
������У |
| PubMed | |
|
Article by ������� |
|
Article by �������� |
|
Article by ������У |
ù������������ϵͳ�Ժ���Ǵ��������е�Ӧ��
�������1, ��������2, ������У1
1. ��һ��ҽ��ѧ�Ϸ�ҽԺƤ���Բ���;
2. ��һ��ҽ��ѧ�Ϸ�ҽԺ�������
Ӧ���������Ƽ�����ϵͳ�Ժ���Ǵ�ȡ���������ɾ�,������Ч�������ڵĸ����ò�����������������,�����������Ƽ��������־�������е���������ҩ��ù���������ƺ���Ǵ����������û��ơ�����ʵ�顢�ٴ�Ӧ�ú����������һ��Ҫ������
1. ��һ��ҽ��ѧ�Ϸ�ҽԺƤ���Բ���;
2. ��һ��ҽ��ѧ�Ϸ�ҽԺ�������
1. ��һ��ҽ��ѧ�Ϸ�ҽԺƤ���Բ���;
2. ��һ��ҽ��ѧ�Ϸ�ҽԺ�������
[2] Eugui EM,Almquist S J,Muller CD,et al.Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro:role of deoxyguanosine nucleotide depletion.Scand J Immunol,1991,33(2):161-173.
[3] Zeevi A.Woan M.Yao GZ.et al.Comparative in vitro studies on thr immunosuppressive activities of mycophenolic acid,bredinin,FK-506,cy closporine,and rapamycin.Transplant Proc,1991,23(6):2928-2930.
[4] Grailer A,Nichols J,Hullett D,et al.Inhibition of human B cell respouses in vitro by RS-61443,cyclosporine A and DAB486IL-2.Trans-plant Proc,1991,23(1 Pt 1):314-315.
[5] Lemster B,Woo J,Strednak J,et al.Cytokine gene expression in murine1ymphocytes activated in the presence of FK-506,bredinin,mycophenolicacid,or brequinar sodium.Transplant Proc,1992,24(6):2845-2846.
[6] Jonsson CA,Erlandsson M.Svensson L,et al.Mycophenolate mofetilameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr/lpr mice.Cell Im-munol.1999.197(2):136-144.
[7] Jonsson CA,Svensson L,Carlsten H.Beneficial effect of the inosinemonophosphate dehydrogenase inhibitor mycophenolate imofetil on survival and se verity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.Clin Exp Immunol,1999,116(3):534-541.
[8] Van Bmggen MC,Walgreen B,Rijke TP,et al.Attenuation of murine lupus nephritis by mycophenolate mofetil.J Am Soc Nephrol,1998,9(8):1407-1415.
[9] McMurray RW,Elboume KB,Lagoo A,et al.Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW Flmouse model of systemic lupus erythematosus.J Rheumatol,1998.25(12):2364-2370.
[10] Glicklich D,Acharya A.Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.Am J Kidney Dis,1998,32 (2):318-322.
[11] Dooley MA,Cosio FG,Nachman PH,et al.Mycophenolate mofetil therapy in luvus nephritis:clinical observations.J Am Soc Nephrol,1999,10 (4):833-839.
[12] Gaubitz M,Schorat A,Schotte H,et al.Mycophenolatemofetil for thetreatment of systemic lupus erythematosus:an open pilot trial.Lupus,1999,8(9):731-736.
[13] Sollinger HW,Belzer FO,Deiehoi MH,et al.RS-61443 (mycophenolatemofetil):a multicenter study for refractory kidney transplant rejection.Ann Surg,1992,216:513-519.
[14] David O,Taylor MD,R.Douglas Ensley,Stephanie L,Olsen et al.Mycophenolate mofetil(RS-61443):Preclinical,Clinical,and Three-year experience in heart transplantation.J Heart Lung Transplant.1994,13:571-582.
[15] Renlund DG,Gopinathan SK,Kfoury AG,et al.Mycophenolate mofetil (MMF) in heart transplantation:rejection prevention and treatment Clin Transplant,1996,10(1 Pt2):136-139.
[16] Dubrey SW,Holt DW,Banner-N.Measurement of mycophenolate mofetilplasma levels after heart transplantation and a potential side effect of highlevels.Ther Drug Monit,1999,21(3):325-326.
[17] Sanchez V,Delgado JF,Blasco T,et al.Benefits of mycophenolate mofetilin cardiac transplant recipients with cyclosporine-induced nephropathy.Transplant-Proc,1999,31(6):2515-2516.